Yoon Jung Jang

5PUBLICATIONS
6CO-AUTHORS
Medical mycologyPredictive and prognostic markersTumour immunologyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2025
Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study.

Yoon Jung Jang, Joonseog Kong, Heyjin Kim

|Dec 19, 2024
Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors.

Yoon Jung Jang, Heyjin Kim, Sang-Young Ryu

|Dec 13, 2023
A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Yoon Jung Jang, Sang Moo Lim, Inki Lee

|Mar 14, 2023
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Yoon Jung Jang, Sang Moo Lim, Inki Lee

|Feb 08, 2022
CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience.

Yoon Jung Jang, Jae Ho Jeong, Jeong Eun Kim

Pageof 1

Frequent Collaborators

1 joint publications

Jae Ho Jeong

1 joint publications

Jeong Eun Kim

1 joint publications

Jin-Hee Ahn

1 joint publications

Kyung Hae Jung